ACTRN12619000453189进行中（未招募）未知
AusTAPER Dem: Team Approach to Polypharmacy Evaluation and Reductionfor General Practice patients with dementia: the Australian TAPER Dem study
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.person with dementia (PWD) - diagnosis of Dementia as recorded by GP
- •2.taking 5 or more medicines (prescribed, over-the-counter, or herbal/ alternative remedies)
- •3.regular patient at a GP practice which is participating in the study
- •4.living in community
排除标准
- •1.inadequate language skills to participate
- •2.are in terminal phase of life
- •3.place of residence is a Residential Aged Care Facility (RACF)
研究者
相似试验
尚未招募
4 期
The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) study for older hospital inpatientsPolypharmacyACTRN12618000979257niversity of Western Australia250
终止
不适用
AusTAPER Pilot: Team Approach to Polypharmacy Evaluation and Reduction A pilot study for older patients in General PracticePolypharmacyPublic Health - Health service researchACTRN12618000978268niversity of Newcastle24
尚未招募
不适用
Team Approach to Polypharmacy Evaluation and Reductionfor General Practice patients: the Australian TAPER (AusTAPER) studyPolypharmacyPublic Health - Health service researchACTRN12620001169932niversity Of Sydney360
进行中（未招募）
不适用
Drug-coated angioplasty balloons for subjects with constriction or blockage in the leg arteries, specifically the Superficial Femoral or Popliteal Arteries: A pharmacokinetic study.ACTRN12613000336785Spectranetics25
尚未招募
3 期
Assessing the effect of Katphala in the management of Prameha (Type 2 Diabetes Mellitus)CTRI/2024/06/069464Post Graduate Institute of Ayurveda DSRRAU Jodhpur